ZA200501559B - Probiotics for gut neuromuscular functions - Google Patents

Probiotics for gut neuromuscular functions

Info

Publication number
ZA200501559B
ZA200501559B ZA200501559A ZA200501559A ZA200501559B ZA 200501559 B ZA200501559 B ZA 200501559B ZA 200501559 A ZA200501559 A ZA 200501559A ZA 200501559 A ZA200501559 A ZA 200501559A ZA 200501559 B ZA200501559 B ZA 200501559B
Authority
ZA
South Africa
Prior art keywords
probiotics
gut
abnormalities
neuromuscular functions
gut neuromuscular
Prior art date
Application number
ZA200501559A
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
Elena Verdu De Bercik
Premysl Bercik
Stehpen M Collins
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29797269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200501559(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of ZA200501559B publication Critical patent/ZA200501559B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200501559A 2002-07-23 2005-02-22 Probiotics for gut neuromuscular functions ZA200501559B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02078064A EP1384483A1 (en) 2002-07-23 2002-07-23 Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function

Publications (1)

Publication Number Publication Date
ZA200501559B true ZA200501559B (en) 2006-05-31

Family

ID=29797269

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501559A ZA200501559B (en) 2002-07-23 2005-02-22 Probiotics for gut neuromuscular functions

Country Status (18)

Country Link
US (1) US8021656B2 (xx)
EP (2) EP1384483A1 (xx)
JP (1) JP2005538087A (xx)
KR (1) KR20050025978A (xx)
CN (1) CN100480370C (xx)
AT (1) ATE534396T1 (xx)
AU (1) AU2003250149B2 (xx)
BR (1) BR0313185A (xx)
CA (1) CA2493255A1 (xx)
ES (1) ES2376664T3 (xx)
IL (1) IL166442A0 (xx)
MX (1) MXPA05000880A (xx)
NO (1) NO20050896L (xx)
NZ (1) NZ538335A (xx)
PT (1) PT1531841E (xx)
RU (2) RU2490325C2 (xx)
WO (1) WO2004009103A1 (xx)
ZA (1) ZA200501559B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1594560A4 (en) * 2003-01-09 2007-06-06 Univ Pennsylvania COMPOSITIONS, METHODS AND KITS ENHANCING THE IMMUNOGENECITY OF A BACTERIAL VACCINE VECTOR
US7749509B2 (en) * 2003-08-29 2010-07-06 Cobb And Company, Llp Treatment of autism using probiotic composition
US7731976B2 (en) * 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
US8192733B2 (en) 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US7759105B2 (en) * 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
PL2351492T3 (pl) * 2005-02-28 2015-02-27 Nutricia Nv Kompozycja odżywcza z probiotykami
ZA200711054B (en) * 2005-07-20 2009-09-30 Unilever Plc Edible product containing beneficial moulds and/or yeasts
WO2007038466A2 (en) * 2005-09-27 2007-04-05 Cobb & Company Treatment of bipolar disorder utilizing anti-fungal compositions
PT1986669E (pt) 2006-02-15 2012-05-15 Nestec Sa Utilização de bifidobacterium longum para a prevenção e tratamento de inflamação
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
MX2008015031A (es) * 2006-05-26 2008-12-05 Nestec Sa Metodos de uso y composiciones nutritivas de extracto de touchi.
EA017558B1 (ru) * 2006-05-28 2013-01-30 Сипла Медпро Ресеч Энд Девелопмент (Пти) Лтд. ШТАММ БАКТЕРИЙ Е.Mundtii ST4SA, СПОСОБНЫЙ ПРОДУЦИРОВАТЬ АНТИБАКТЕРИАЛЬНЫЙ ПЕПТИД ST4SA, СПОСОБ ПОЛУЧЕНИЯ ПЕПТИДА ST4SA И ПРИМЕНЕНИЕ ШТАММА БАКТЕРИЙ Е.Mundtii ST4SA И ПЕПТИДА
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US9055763B2 (en) * 2007-10-11 2015-06-16 Dupont Nutrition Biosciences Aps Probiotics for use in relieving symptoms associated with gastronitestinal disorders
ES2395838T3 (es) * 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
CA2724554A1 (en) * 2008-05-15 2009-11-19 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
MX336030B (es) * 2009-05-11 2016-01-07 Nestec Sa Lactobacillus johnsonii la1 mcc533 (cncm i-1225) y padecimientos inmunes.
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2289527B1 (en) * 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
CN102905712B (zh) * 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
WO2012020014A1 (en) 2010-08-10 2012-02-16 Chr. Hansen A/S Nematocidal composition comprising bacillus subtilis and bacillus licheniformis
EP2455094A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US20130045185A1 (en) * 2011-08-18 2013-02-21 Dupont Nutrition Biosciences Aps Strains and methods useful for mycotoxins
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US20140079676A1 (en) * 2012-09-20 2014-03-20 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
MX2015005165A (es) * 2012-10-25 2015-10-29 Gervais Danone Sa Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
PT3016527T (pt) 2013-06-03 2018-11-09 Proprev Ab Tratamento da obesidade, síndrome metabólica, diabetes tipo 2, doenças cardiovasculares, demência, doença de alzheimer e doença inflamatória usando pelo menos uma estirpe bacteriana de prevotella
ES2683190T3 (es) * 2013-08-09 2018-09-25 Ab-Biotics S.A. Probiótico para el llanto infantil excesivo
CN103497988B (zh) * 2013-09-23 2014-10-29 广州康代生物科技有限公司 一种安全高效乳酸菌产品的发酵生产方法
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
RU2608871C1 (ru) * 2015-11-06 2017-01-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" Штамм бактерий Lactobacillus paracasei 1, используемый для приготовления пробиотического препарата
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN105767507B (zh) * 2016-03-30 2020-12-01 遂平广源饲料科技有限公司 一种饲料用微生态制剂、无抗饲料及其制备方法
KR101765559B1 (ko) * 2016-09-27 2017-08-07 이대희 노루궁뎅이버섯을 포함하는 프로바이오틱스 조성물
KR20210141920A (ko) * 2018-12-21 2021-11-23 킴벌리-클라크 월드와이드, 인크. 요실금, 과민성 방광, 또는 월경 경련을 예방 또는 치료하기 위한 조성물 및 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
WO1999017788A1 (en) 1997-10-06 1999-04-15 Abbott Laboratories Composition of treatment of candidiasis
CN1244684C (zh) * 1999-03-11 2006-03-08 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
US6926891B1 (en) * 1999-08-05 2005-08-09 Nestec S.A. Treatment of diarrhea with strains of Bifidobacterium longum
CA2396958C (en) * 2000-01-18 2009-11-17 Societe Des Produits Nestle S.A. Pet food composition for treating gastric helicobacter-like organisms (ghlos) in pets
CA2403491A1 (en) * 2000-03-24 2001-09-27 Societe Des Produits Nestle, S.A. Use of lactic acid bacterium for the prevention of peritonitis
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
IT1320772B1 (it) 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
AU2002256620B2 (en) * 2001-02-19 2007-01-18 Societe Des Produits Nestle S.A. Consumable product containing probiotics
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
WO2004009103A1 (en) 2004-01-29
US20070128178A1 (en) 2007-06-07
AU2003250149B2 (en) 2009-01-22
CA2493255A1 (en) 2004-01-29
EP1531841A1 (en) 2005-05-25
IL166442A0 (en) 2006-01-15
RU2346036C2 (ru) 2009-02-10
RU2005104950A (ru) 2005-12-10
MXPA05000880A (es) 2006-01-24
EP1384483A1 (en) 2004-01-28
ES2376664T3 (es) 2012-03-15
AU2003250149A1 (en) 2004-02-09
CN100480370C (zh) 2009-04-22
KR20050025978A (ko) 2005-03-14
JP2005538087A (ja) 2005-12-15
RU2008132327A (ru) 2010-02-10
NZ538335A (en) 2007-04-27
CN1678329A (zh) 2005-10-05
EP1531841B1 (en) 2011-11-23
US8021656B2 (en) 2011-09-20
ATE534396T1 (de) 2011-12-15
BR0313185A (pt) 2005-06-21
PT1531841E (pt) 2012-02-01
RU2490325C2 (ru) 2013-08-20
NO20050896L (no) 2005-04-18

Similar Documents

Publication Publication Date Title
ZA200501559B (en) Probiotics for gut neuromuscular functions
IL153989A (en) Nutritional composition comprising mixture of functional carbohydrates
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
EP2497501A3 (en) Radionuclides for medical use
IL161995A (en) Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
IL122196A0 (en) Bicyclic-aromatic compounds
HK1085927A1 (en) The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes
MXPA01012641A (es) Composicion que comprende esfingomielinasa alcalina para uso como una preparacion dietetica, suplemento alimenticio o producto farmaceutico.
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
PL373034A1 (en) Rapidly disintegrating tablet
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
WO2002028430A3 (en) Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
RU2002127274A (ru) Применение препарата ветом-7048 впервые в качестве лекарственного препарата при лечении атрофии мозга, гидроцефалии мозга
UA34283A (uk) Спосіб діагностики порушень імунологічного статусу у людини та тварин
GEP20053729B (en) Stomatological Combination, Medicinal- Prophylactic Means and Their Use
ES2199687A1 (es) Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.
UA41089A (uk) Спосіб профілактики йодного дефіциту у дітей